The CanVasc website     

English - French

  Home   |    About CanVasc   |   Vasculitides   |   Ongoing studies   |   Meetings   | Tools for physicians    |   Links

 

DISCOVER CanVasc and its affiliated centers across Canada

CanVasc is the Canadian network for research on vasculitides. It was created in November 2011 by Drs. Pagnoux, Carette and Khalidi. First task was to identify other referal medical centers and physicians across Canada with expertise in vasculitis and willing to be part of this new research group. Among its several other aims, important ones are to help conducting studies on vasculitis, provide support and educational material on vasculitides for physicians and trainees and, eventually, optimize the therapeutic management of patients with these rare diseases in order to further improve their outcomes. CLICK HERE for more information on CanVasc. 

BECOME A CanVasc MEMBER

If you are a health care provider and are interested in vasculitides and Canadian Vasculitis network activities, simply register by sending us an email with your name, surname, profession, address and full affiliations. At this time, membership is totally free and does not imply anything for you. As a non-profit non-commercial research network, you will not receive any other unsollicited mailing from us or others. We may (just and only) send you information on the CanVasc meetings or ongoing trials, a coupe of times per year.

UPDATE YOUR KNOWLEDGE on vasculitis with the CanVasc reviews of recent articles

Several CanVasc core members are regularly adding commented summaries of selected and important articles on vasculitis, for physicians to keep pace with scientific publications on vasculitis. Read these summaries on the Vasculitis page now !

Among the latest news:

  • ACR vasculitis abstracts review (a quick glance on most important abstracts presented in Chicago in November 2011).- 17 January 2012.
  • A notice of Compliance (NOC) has been issued on December 13th, 2011, by Health Canada  for rituximab, in combination with glucocorticoids, for the induction of remission in adult patients with severely active Granulomatosis with Polyangiitis (GPA, also known as Wegener's Granulomatosis) and Microscopic Polyangiitis (MPA).- 13 December 2011
  • Neutrophil microparticles play a potential pathogenic role in ANCA vasculitis (GPA).- 11 december 2011.
  • Induction therapy for GPA/MPA based on oral cyclophosphamide is associated with a lower relapse rate, as compared to IV pulse cyclophosphamide, 4 years after CYCLOPS study closure. 10 December 2011.

READ MORE on these topics and others on the Vasculitis page !

The 1st Annual CanVasc meeting was held in Toronto Friday 10 June 2011.

There were almost 70 attendees over the entire day. Have look at the meeting webpage and upload some of the presentations made that day. Next meeting is planned to be held next November, in Montréal, QC (further detail to be posted soon). 

Other meetings or conferences on vasculitides are scheduled within the next months. Information are available on the meeting webpage .

This Website was updated the 18 January 2012 by Dr Christian Pagnoux